+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Enuresis Drug"

Nocturnal Enuresis - Pipeline Insight, 2024 - Product Thumbnail Image

Nocturnal Enuresis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Nocturnal Enuresis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Nocturnal Enuresis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Enuresis Drug market is a subset of the Urological Disorders Drugs market, which includes medications used to treat a variety of conditions related to the urinary tract. Enuresis Drugs are used to treat bedwetting, a condition in which a person involuntarily urinates while asleep. These drugs are typically prescribed to children and adolescents, although adults may also be prescribed them. Enuresis Drugs work by reducing the amount of urine produced at night, or by increasing the amount of time between urination. The Enuresis Drug market is highly competitive, with a variety of companies offering different products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. Other companies in the market include Astellas Pharma, Allergan, and Mylan. Show Less Read more